ResMed

Youtube Subscribe

Open: 144.82 Close: 134.65 Change: -10.17

9 risks of investing in ResMed Company Inc found by an AI after reading the whole internet.

This document will help you to evaluate ResMed without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ResMed are: ResMed, Inc, revenue, device, CPAP, machine, institutional, and the …

Concept Map

Semantic Network

Stock Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications. The company also provides AirView, a cloud--based system that enables remote monitoring and changing of patients' device settings..

Today's Summary

ResMed Inc. (NYse:rmd) institutional owners may please ResMed inc. institutional owners. Needham reiterated a Buy rating on ResMed (NYSE:RMD) with a price target of $180. ResMed reported revenue of $1.1 billion for the first quarter of fiscal year 2024.

Today's News

The ResMed AirMini is a dependable, well-liked model. Bluetooth connectivity and Bluetooth connectivity enable you to track your therapy data. Only ResMed masks are compatible with this machine. ResMed Inc. (NYse:rmd) institutional owners may please ResMed inc. (nyse:RMD) institutional owner. Following a 34% decline over last year, recent gains may please resmed inc. institutional owners. ResMed declares $0.48 dividend. Non-GAAP EPS of $1.64 beats by $0.02, revenue of $ 1.1B misses by $10M. ResMed is one of the largest respiratory care device companies. Duality Advisers LP Acquires New Shares in ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript. ResMed posted profits of $219.4 million in the first quarter. ResMed has seen its revenue spike amid the massive recall at competitor Philips. Arthur Begetis has been back in his native Down Under since assuming the real estate role in July 2022 after seven years of managing ResMeds international tax activities. ResMed Inc. stock rises monday, outperforms market - marketwatch. resmed inc. stock falls thursday, underperforms market. Shares of Resmed Inc. (NYSE:RMD) - 2.94% SPX -0.48% DJIA -1.12% Shares of. resmed deal of the day! - the CPAP Shop. ResMed Inc. recently declared a quarterly dividend, which was paid on Thursday, September 21st. This is an increase from ResMeds previous quarterly dividend of $0.44. ResMed had a net margin of 21.25% and a return on equity of 24.94% Sell-side analysts forecast that ResMed will continue to beat the market. Needham reiterated a Buy rating on ResMed Inc. (NYSE:RMD) with a price target of $180. ResMed registered a street-beating performance in the first quarter, where revenue increased by 16% to $1.1 billion. ResMed is a California-based medical device company that manufactures and distributes cloud-connected devices for the treatment of sleep-related breathing disorders. ResMed makes continuous-positive-airway-pressure machines (CPAP) to treat sleep apnea, a condition where the airway gets repeatedly blocked while sleeping. ResMed reported revenue of $1.1 billion for the first quarter of fiscal year 2024, a 16% increase. CEO Mick Farrell said the actions that the company is taking to “accelerate profitable growth across ResMed and to power our long-term success” ResMed AirSense™ 11 is the latest CPAP machine model of the popular AirSense series by ResMed. With this CPAP device, you get access to the ResMed myAir app.

Stock Profile

"ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California."

Keywords

The game is changing. There is a new strategy to evaluate ResMed fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ResMed are: ResMed, Inc, revenue, device, CPAP, machine, institutional, and the most common words in the summary are: resmed, cpap, machine, market, stock, price, mask, . One of the sentences in the summary was: institutional owners. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #resmed #cpap #machine #market #stock #price #mask.

Read more →

Youtube Subscribe

---